Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction

Robert Dragu1, Shafik Huri1, Robert Zukermann1

  • 1Department of Cardiology, Rambam Medical Center and the Bruce Rappaport Faculty of Medicine, Haifa, Israel.

Atherosclerosis
|December 19, 2006
PubMed

Insights

Elevated neutrophil counts are the strongest predictor of mortality in acute myocardial infarction (AMI) patients. This finding highlights neutrophils as key biomarkers for adverse outcomes in AMI.

Area of Science:

  • Cardiology
  • Hematology
  • Clinical Pathology

Background:

  • Elevated total white blood cell (WBC) count is linked to increased mortality in acute coronary syndromes.
  • The specific leukocyte subset that best predicts adverse outcomes remains unclear.

Purpose of the Study:

  • To investigate the predictive value of distinct white blood cell (WBC) subtypes for long-term mortality in patients with acute myocardial infarction (AMI).

Main Methods:

  • Prospective study of 1037 AMI patients.
  • Baseline measurements included total WBC, neutrophil, monocyte, and lymphocyte counts, and high-sensitivity C-reactive protein (CRP).
  • Long-term mortality was assessed over a median follow-up of 23 months.

Main Results:

  • Independently, elevated neutrophil counts (upper quartile) were strong predictors of mortality (HR 2.7).
  • Neutrophil count improved predictive models incorporating total WBC, monocyte, or lymphocyte counts.
  • Neutrophil count remained a significant predictor after adjusting for left ventricular systolic function and CRP.

Conclusions:

  • Elevated neutrophil count is the strongest correlate of mortality among WBC subtypes in AMI patients.
  • Neutrophil count offers additive prognostic value when used alongside CRP levels.
Abstract